Biohaven Pharmaceutical Holding Company Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$408,168,000 over the previous period. Total operating expenses were $436,051,000.
Profit Margin
| 2017 | 0 | 0 | |
|---|---|---|---|
| 2019 | 0 | -528.80M | |
| 2020 | 0 | -118.66M | |
| 2021 | 462.50M | -213.79M | -46.23% |
| 2022 | 0 | -570.27M | |
| 2023 | 0 | -408.16M |
BHVN Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 462.50M | 0 | 0 | 0 |
Cost of revenue | 3.36M | 1.38M | 91.66M | 72K | 0 | 0 |
Gross profit | -3.36M | -1.38M | 370.84M | -72K | 0 | 0 |
Operating exp. | ||||||
Research and development | 373.28M | 437.07M | 181.48M | 98.46M | 344.67M | 0 |
Selling and marketing | 5.87M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 436.05M | 567.93M | 218.9M | 114.50M | 479.12M | 0 |
Operating income | -436.05M | -567.93M | -218.9M | -114.50M | -479.12M | 0 |
Other income (expenses), net | 26.5M | -1.90M | 6.47M | -4.16M | -49.26M | 0 |
Income before tax | -409.55M | -569.84M | -212.43M | -118.66M | -528.38M | 0 |
Income tax expense | -1.38M | 438K | 1.36M | -134.29K | 419K | 0 |
Net income | -408.16M | -570.27M | -213.79M | -118.66M | -528.80M | 0 |
Earnings per share | ||||||
Basic EPS | -5.73 | -12.75 | -5.97 | -3.31 | -10.91 | 0 |
Diluted EPS | -5.73 | -12.75 | -5.97 | -3.31 | -10.91 | 0 |
| Data source | Data source | Data source | Data source | Data source |